H. Sasaki

H. Sasaki, S. Kondo, T. Toyama, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Acetaldehyde production by non‐pathogenic Neisseria in human oral microflora: Implications for carcinogenesis in upper aerodigestive tract

H. Sasaki, H. Esumi, Y. Kashiwase, 2000, International journal of cancer.

Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer.

H. Sasaki, S. Moriyama, Y. Nakashima, 2001, Cancer letters.

Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2011, The Journal of surgical research.

Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.

H. Sasaki, C. Dumontet, M. Yano, 2008, Lung cancer.

Expression of the Prothymosin-α Gene as a Prognostic Factor in Lung Cancer

H. Sasaki, Y. Yamakawa, M. Kiriyama, 2001, Surgery Today.

Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.

H. Sasaki, Satoru Takahashi, Y. Yamashita, 2014, Oncology reports.

Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma

Masaki Hara, Eriko Suzuki, Yoshitaka Fujii, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay.

H. Sasaki, M. Takada, M. Yano, 2005, Lung cancer.

Prognostic factors of pathologic stage IB non-small cell lung cancer.

H. Sasaki, S. Moriyama, M. Yano, 2011, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Polymorphisms in intron 1 of the EGFR gene in non-small cell lung cancer patients

H. Sasaki, A. Kubo, M. Takada, 2012, Experimental and therapeutic medicine.

Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery

H. Sasaki, S. Moriyama, Y. Nakashima, 2003, Gene Therapy.

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2009, Lung cancer.

Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.

H. Sasaki, M. Yano, Y. Fujii, 2006, Lung cancer.

βIGH3, a TGF-β Inducible Gene, is Overexpressed in Lung Cancer

H. Sasaki, S. Moriyama, Y. Nakashima, 2002 .

Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.

H. Sasaki, Y. Nakashima, M. Kaji, 2001, The Journal of surgical research.

Saber-sheath malacic trachea remodeled and fixed into a normal shape by long-term placement and then removal of gianturco wire stent.

H. Sasaki, M. Yano, M. Kaji, 2003, The Annals of thoracic surgery.

Post-operative acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection.

H. Sasaki, S. Moriyama, M. Yano, 2012, Interactive cardiovascular and thoracic surgery.

Identification of Pleural Effusion with Low Levels of Adenosine Deaminase but Without Signs of Acute Inflammation or Pleural Thickening to Diagnose Early Malignant Pleural Mesothelioma

H. Sasaki, S. Moriyama, M. Yano, 2012 .

A safe method for marking small pulmonary nodules with crystal violet

H. Sasaki, S. Moriyama, M. Yano, 2015, Surgery Today.

Gelatinolytic activity of matrix metalloproteinase in lung cancer studied using film in situ zymography stamp method.

H. Sasaki, S. Moriyama, M. Kaji, 2003, Lung cancer.

Expression of the MTA1 mRNA in advanced lung cancer.

H. Sasaki, S. Moriyama, Y. Nakashima, 2002, Lung cancer.

Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer

H. Sasaki, S. Moriyama, Y. Nakashima, 2001, International journal of cancer.

Expression of Periostin, Homologous with an Insect Cell Adhesion Molecule, as a Prognostic Marker in Non‐small Cell Lung Cancers

M. Loda, D. Auclair, H. Sasaki, 2001, Japanese journal of cancer research : Gann.

Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer.

H. Sasaki, S. Moriyama, Y. Nakashima, 2001, Lung cancer.

A case of small lung cancer with solitary skip metastasis of unilateral supraclavicular lymph node

H. Sasaki, S. Moriyama, M. Yano, 2011 .

Laparoscopic Adrenalectomy for Solitary Adrenal Metastasis From Lung Cancer

H. Sasaki, K. Tozawa, M. Yano, 2014, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L.

H. Sasaki, T. Yamanaka, Y. Ichinose, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

MRP3 gene expression correlates with NRF2 mutations in lung squamous cell carcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2012, Molecular medicine reports.

Increased NRF2 gene (NFE2L2) copy number correlates with mutations in lung squamous cell carcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2012, Molecular medicine reports.

Increased NRF 2 gene ( NFE 2 L 2 ) copy number correlates with mutations in lung squamous cell carcinomas

H. Sasaki, S. Moriyama, M. Yano, 2012 .

NFE2L2 Gene Mutation in Male Japanese Squamous Cell Carcinoma of the Lung

H. Sasaki, S. Moriyama, M. Yano, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Autoantibody to Gravin is Expressed More Strongly in Younger and Nonthymomatous Patients with Myasthenia Gravis

H. Sasaki, M. Kunimatsu, Y. Yamakawa, 2001, Surgery Today.

Methylation of the DLEC 1 gene correlates with poor prognosis in Japanese lung cancer patients

H. Sasaki, S. Moriyama, M. Yano, 2010 .

Methylation of the DLEC1 gene correlates with poor prognosis in Japanese lung cancer patients.

H. Sasaki, S. Moriyama, M. Yano, 2010, Oncology letters.

MEK1 and AKT2 Mutations in Japanese Lung Cancer

H. Sasaki, S. Moriyama, M. Yano, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Hypermethylation of the large tumor suppressor genes in Japanese lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2010, Oncology letters.

MEK1 gene mutation in Japanese lung adenocarcinoma patients.

H. Sasaki, M. Yano, Y. Fujii, 2009, Molecular medicine reports.

EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer

H. Sasaki, A. Kubo, M. Takada, 2009, Journal of Cancer Research and Clinical Oncology.

AKT1 and AKT2 mutations in lung cancer in a Japanese population.

H. Sasaki, M. Yano, Y. Fujii, 2008, Molecular medicine reports.

ErbB4 expression and mutation in Japanese patients with lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2007, Clinical lung cancer.

Mutation of epidermal growth factor receptor gene in adenosquamous carcinoma of the lung.

H. Sasaki, M. Yano, Y. Fujii, 2007, Lung cancer.

CCND1 messenger RNA expression is correlated with EGFR mutation status in lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2007, Clinical lung cancer.

Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.

H. Sasaki, M. Yano, Y. Fujii, 2006, Japanese journal of clinical oncology.

Metachronous Second Primary Lung Cancer Resection

H. Sasaki, M. Yano, Y. Fujii, 2005 .

Uncommon V599E BRAF mutations in Japanese patients with lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2006, The Journal of surgical research.

Decreased fragile histidine triad gene messenger RNA expression in lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2006, Clinical lung cancer.

FHIT mRNA expression in thymoma.

H. Sasaki, M. Yano, Y. Fujii, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

EGFR and erbB2 mutation status in Japanese lung cancer patients

H. Sasaki, M. Takada, M. Yano, 2006, International journal of cancer.

HRad17 Colocalizes with NHP2L1 in the Nucleolus and Redistributes after UV Irradiation*

D. Auclair, H. Sasaki, Yuan Liu, 1999, The Journal of Biological Chemistry.

Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer.

H. Sasaki, Y. Fujii, M. Kimura, 2002, Japanese journal of clinical oncology.

Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 in vitro.

H. Sasaki, Jeffrey L. Brown, S. Moriyama, 2014, Molecular and clinical oncology.

Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.

Tomoki Yokoyama, Yoshitaka Fujii, Motoki Yano, 2007, Oncology reports.

Evaluation of Kras gene mutation and copy number in thymic carcinomas and thymomas.

H. Sasaki, M. Yano, Y. Fujii, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expression of PPAR-gamma is correlated with the clinical course of neuroblastoma.

H. Sasaki, S. Kondo, T. Toyama, 2003, Journal of pediatric surgery.

Number of recurrent lesions is a prognostic factor in recurrent thymoma.

H. Sasaki, S. Moriyama, M. Yano, 2011, Interactive cardiovascular and thoracic surgery.

Preservation of phrenic nerve involved by stage III thymoma.

H. Sasaki, S. Moriyama, M. Yano, 2010, The Annals of thoracic surgery.

Thymic carcinoma with dissemination: a retrospective analysis of ten patients

H. Sasaki, M. Yano, Y. Fujii, 2008, General thoracic and cardiovascular surgery.

PD-L1 gene expression in Japanese lung cancer patients.

H. Sasaki, S. Moriyama, M. Yano, 2013, Biomedical reports.

Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer.

H. Sasaki, S. Moriyama, M. Yano, 2012, Oncology letters.

Elevated Serum Pro-MMP2 Levels in Patients with Stage IV Thymoma

H. Sasaki, M. Kaji, Y. Yamakawa, 2002, Surgery Today.

Elevated Serum Pro-MMP2 Levels in Patients with Advanced Lung Cancer Are Not Suitable as a Prognostic Marker

H. Sasaki, Y. Yamakawa, M. Kiriyama, 2002, Surgery Today.

PIK3CA mutation status in Japanese lung cancer patients.

H. Sasaki, M. Yano, Y. Fujii, 2006, Lung cancer.

Expression of the periostin mRNA level in neuroblastoma.

H. Sasaki, S. Kondo, Y. Yamakawa, 2002, Journal of pediatric surgery.

Advances in Brief HRad 17 , a Human Homologue of the Schizosaccharomyces pombe Checkpoint Gene rad 17 , Is Overexpressed in Colon Carcinoma 1

M. Loda, D. Auclair, H. Sasaki, 2000 .

HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint gene rad17, is overexpressed in colon carcinoma.

M. Loda, D. Auclair, H. Sasaki, 1999, Cancer research.

Endostatin gene transfection using a cationic lipid: advantages of transfection before tumor cell inoculation and repeated transfection

H. Sasaki, R. Scheule, Y. Nakashima, 2004, Cancer Gene Therapy.

Polymorphisms of NRF2 gene correlated with decreased FEV1 in lung cancers of smokers.

H. Sasaki, S. Moriyama, M. Yano, 2013, Biomedical reports.

Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome of Lung Cancer

H. Sasaki, 2016 .

Expression of AIRE in thymocytes and peripheral lymphocytes

H. Sasaki, M. Yano, Y. Fujii, 2008, Autoimmunity.

Hrad17 expression in thymoma.

H. Sasaki, M. Yano, M. Kaji, 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.

A. Berchuck, H. Sasaki, H. Takahashi, 1993, Cancer research.

Expression of thymidylate synthase and orotate phosphoribosyltransferase in thymic carcinoma

H. Sasaki, S. Moriyama, M. Yano, 2012, Experimental and therapeutic medicine.

Expression of the prothymosin α mRNA correlated with that of N-myc in neuroblastoma

H. Sasaki, S. Kondo, Y. Yamakawa, 2001 .

PIK3CA mutation status in Japanese esophageal squamous cell carcinoma.

H. Sasaki, Y. Fujii, M. Kimura, 2008, The Journal of surgical research.

Novel chemiluminescence assay for serum periostin levels in women with preeclampsia and in normotensive pregnant women.

D. Auclair, H. Sasaki, Y. Fujii, 2002, American journal of obstetrics and gynecology.

Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer

H. Sasaki, M. Yano, M. Kaji, 2003, International Journal of Clinical Oncology.

Ets-1 gene expression in patients with thymoma.

H. Sasaki, M. Yano, M. Kaji, 2002, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation

H. Sasaki, T. Setoguchi, Y. Matsunoshita, 2009, British Journal of Cancer.

Developmentally regulated expression of survivin in the human thymus.

H. Sasaki, Y. Yamakawa, M. Kiriyama, 2002, Human immunology.

Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma.

H. Sasaki, S. Moriyama, Y. Nakashima, 2003, The Journal of surgical research.

Beta IGH3, a TGF-beta inducible gene, is overexpressed in lung cancer.

H. Sasaki, S. Moriyama, Y. Nakashima, 2002, Japanese journal of clinical oncology.

Expression of the MTA1 mRNA in thymoma patients.

H. Sasaki, Y. Nakashima, M. Kaji, 2001, Cancer letters.

Expression of the cdc25B mRNA correlated with that of N-myc in neuroblastoma.

H. Sasaki, S. Kondo, Y. Yamakawa, 2001, Japanese journal of clinical oncology.

Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Levels in Thymoma

H. Sasaki, M. Yano, M. Kaji, 2003, Surgery Today.

Right partial anomalous pulmonary venous connection found during lobectomy for coexisting lung cancer and tuberculosis: report of a case.

H. Sasaki, Hisaichi Tanaka, M. Okumura, 2006, Clinical lung cancer.

Endoscopic thoracic sympathectomy for palmar hyperhidrosis: efficacy of T2 and T3 ganglion resection.

H. Sasaki, M. Yano, M. Kiriyama, 2005, Surgery.

Expression of Smac/DIABLO is a novel prognostic marker in lung cancer.

Kotaro Mizuno, Yoshitaka Fujii, Ichiro Fukai, 2004, Oncology reports.

Glycosylphosphatidyl inositol‐anchored protein (GPI‐80) gene expression is correlated with human thymoma stage

H. Sasaki, Y. Fujii, I. Fukai, 2003, Cancer science.

A case of primary pulmonary collision tumor consisting of adenocarcinoma and squamous cell carcinoma

H. Sasaki, M. Yano, Y. Fujii, 2008 .

Elevated plasma thymosin-a1 levels in lung cancer patients

H. Sasaki, Y. Yamakawa, Yushi Saito, 1997 .

Characteristics of Lung Cancers Harboring NRAS Mutations

M. Ladanyi, C. Rudin, M. Kris, 2013, Clinical Cancer Research.

Oncogenic and drug sensitive NTRK1 rearrangements in lung cancer

L. Garraway, P. Stephens, P. Jänne, 2013, Nature Medicine.

Erratum: Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

J. Rothberg, J. Leamon, J. Simons, 2006, Nature Medicine.

Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification.

Rameen Beroukhim, Matthew Meyerson, Xiaojun Zhao, 2004, Nucleic acids research.

Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells

H. Sasaki, T. Setoguchi, Y. Matsunoshita, 2009, British Journal of Cancer.

ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.

H. Sasaki, M. Yano, Y. Fujii, 2008, The Journal of surgical research.

Allelotype of endometrial carcinoma.

H. Sasaki, J. Barrett, H. Takahashi, 1994, Cancer research.

Increased BRAF copy number in lung adenocarcinoma

H. Sasaki, S. Moriyama, M. Yano, 2014, Oncology letters.

Evaluation of Kras Gene Mutation and Copy Number Gain in Non-small Cell Lung Cancer

H. Sasaki, S. Moriyama, M. Yano, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PIK3CA gene amplification in Japanese non-small cell lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2007, Lung cancer.

Genotype analysis of the NRF2 gene mutation in lung cancer.

H. Sasaki, S. Moriyama, M. Yano, 2013, International journal of molecular medicine.

Gene expression analysis of human thymoma correlates with tumor stage

H. Sasaki, Y. Yamakawa, M. Kiriyama, 2002, International journal of cancer.

CHRNA5 gene D398N polymorphism in Japanese lung adenocarcinoma.

H. Sasaki, M. Yano, Y. Fujii, 2010, The Journal of surgical research.

DDR2 polymorphisms and mRNA expression in lung cancers of Japanese patients.

H. Sasaki, S. Moriyama, M. Yano, 2012, Oncology letters.

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors

M. Meyerson, A. Protopopov, Xiaojun Zhao, 2006, Proceedings of the National Academy of Sciences of the United States of America.

A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.

H. Sasaki, N. Lindeman, M. Yano, 2006, Japanese journal of clinical oncology.

Genetic profiling of thymic carcinoma using targeted next-generation sequencing.

H. Sasaki, S. Moriyama, M. Yano, 2014, Lung cancer.

Thymic Carcinoma: 30 Cases at a Single Institution

H. Sasaki, Sadao Suzuki, M. Yano, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Arg and DAP3 expression was correlated with human thymoma stage

H. Sasaki, Y. Yamakawa, Y. Fujii, 2004, Clinical & Experimental Metastasis.

Increased Sox2 copy number in lung squamous cell carcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2012, Experimental and therapeutic medicine.

Increased Sox 2 copy number in lung squamous cell carcinomas

H. Sasaki, S. Moriyama, M. Yano, 2022 .

Elevated Serum Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Levels in Patients with Thymic Epithelial Neoplasms

H. Sasaki, S. Moriyama, Y. Nakashima, 2001, Surgery Today.

Pedunculated solitary fibrous tumor of the pleura manifesting as a migrating chest mass: report of a case

H. Sasaki, S. Moriyama, M. Yano, 2012, Surgery Today.

RagD gene expression and NRF2 mutations in lung squamous cell carcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2012, Oncology letters.

HIN-1, an inhibitor of cell growth, invasion, and AKT activation.

H. Sasaki, K. Polyak, R. Gelman, 2005, Cancer research.

Thymoma with Dissemination: Efficacy of Macroscopic Total Resection of Disseminated Nodules

H. Sasaki, M. Yano, Y. Fujii, 2009, World Journal of Surgery.

Genotyping analyses for polymorphisms of ANXA5 gene in patients with recurrent pregnancy loss.

H. Sasaki, Sadao Suzuki, N. Suzumori, 2013, Fertility and sterility.

Bmc Cancer

H. Sasaki, N. Kondo, Satoru Takahashi, 2008 .

Cten mRNA Expression Is Correlated with Tumor Progression in Thymoma

H. Sasaki, Y. Fujii, H. Yukiue, 2003, Tumor Biology.

Cten mRNA expression was correlated with tumor progression in lung cancers.

H. Sasaki, S. Moriyama, M. Yano, 2003, Lung cancer.

EGFRvIII mutation in lung cancer correlates with increased EGFR copy number.

H. Sasaki, M. Yano, Y. Fujii, 2007, Oncology reports.

Long Exposure of Environmental Tobacco Smoke Associated with Activating EGFR Mutations in Never-Smokers with Non–Small Cell Lung Cancer

H. Sasaki, M. Ando, A. Kubo, 2010, Clinical Cancer Research.

LKB1 gene alterations in surgically resectable adenocarcinoma of the lung

H. Sasaki, S. Moriyama, M. Yano, 2009, Surgery Today.

EGFR exon 20 insertion mutation in Japanese lung cancer.

H. Sasaki, M. Takada, M. Yano, 2007, Lung cancer.

Identification of Recurrent FGFR3–TACC3 Fusion Oncogenes from Lung Adenocarcinoma

P. Jänne, P. Hammerman, H. Sasaki, 2014, Clinical Cancer Research.

Increased FGFR 1 copy number in lung squamous cell carcinomas

H. Sasaki, S. Moriyama, M. Yano, 2022 .

Intra-tumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2015, Experimental and therapeutic medicine.

EGFR Mutation Status in Japanese Lung Cancer Patients: Genotyping Analysis Using LightCycler

H. Sasaki, M. Takada, M. Yano, 2005, Clinical Cancer Research.

Prognosis of recurrent non-small cell lung cancer following complete resection

H. Sasaki, S. Moriyama, M. Yano, 2014, Oncology letters.

Extracellular Domain Mutation of ErbB 2 Status in Japanese Lung Cancer Patients

Moriyama, H. Sasaki, Shitara, 2013 .

Braf and erbB 2 mutations correlate with smoking status in lung cancer patients

H. Sasaki, S. Moriyama, M. Yano, 2012 .

Predictive Biomarkers and Personalized Medicine Characteristics of Lung Cancers Harboring NRAS Mutations

M. Ladanyi, C. Rudin, M. Kris, 2013 .

Epidermal growth factor receptor mutations and gene amplification in Japanese non-small cell lung cancer patients treated with gefitinib.

H. Sasaki, M. Kitaichi, T. Kawaguchi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Met gene copy number predicts the prognosis for completely resected non‐small cell lung cancer

H. Sasaki, M. Yano, Y. Fujii, 2008, Cancer science.

Braf and erbB2 mutations correlate with smoking status in lung cancer patients.

H. Sasaki, S. Moriyama, M. Yano, 2012, Experimental and therapeutic medicine.

Multicystic Mesothelial Cyst of the Mediastinum: Report of a Case

H. Sasaki, M. Yano, M. Kaji, 2003, Surgery Today.

Anomalous Origin of Right Upper Lobe Bronchus in a Patient With Lung Cancer

H. Sasaki, M. Yano, M. Kaji, 2003 .

Endobronchial neodymium:yttrium-aluminum garnet laser for noninvasive closure of small proximal bronchopleural fistula after lung resection.

H. Sasaki, M. Yano, M. Kaji, 2002, The Annals of thoracic surgery.

Tracheal carcinoma requiring anterior mediastinal tracheostomy report of a case

H. Sasaki, S. Kondo, Y. Yamakawa, 1997 .

Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in Japanese lung adenocarcinoma.

H. Sasaki, S. Moriyama, M. Yano, 2013, Lung cancer.

Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer.

H. Sasaki, S. Moriyama, Y. Nakashima, 2001, Japanese journal of clinical oncology.

PD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.

H. Sasaki, S. Moriyama, M. Yano, 2014, Molecular and clinical oncology.

PD ‐ L 1 gene expression in Japanese lung cancer patients

H. Sasaki, S. Moriyama, M. Yano, 2012 .

Preoperative steroid pulse therapy for invasive thymoma

H. Sasaki, M. Yano, Y. Fujii, 2006, Cancer.

Chromosome 6 abnormalities correlated with thymoma progression.

H. Sasaki, Y. Fujii, N. Ide, 2003, The American journal of pathology.

Histone deacetylase 1 mRNA expression in lung cancer.

Yoshitaka Fujii, Ichiro Fukai, Yoshiaki Nakashima, 2004, Lung cancer.

PD 1 Gene Promoter Polymorphism in Thymoma and Myasthenia Gravis

H. Sasaki, S. Moriyama, M. Yano, 2014 .

SAGE mRNA expression in advanced-stage lung cancers.

H. Sasaki, S. Moriyama, M. Yano, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Thymoma associated with fatal myocarditis and polymyositis in a 58-year-old man following treatment with carboplatin and paclitaxel: A case report.

H. Sasaki, M. Yano, Y. Fujii, 2012, Oncology letters.

Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients.

D. Auclair, H. Sasaki, M. Kaji, 2001, Cancer letters.

Decreased Hrad6B expression in lung cancer

Yoshitaka Fujii, Ichiro Fukai, Yoshiaki Nakashima, 2004, Acta oncologica.

Angioarrestin mRNA expression in early-stage lung cancers.

H. Sasaki, S. Moriyama, M. Yano, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2011, Molecular medicine reports.

A case report of pyothorax-associated lymphoma successfully treated by pleuropneumonectomy following radiation therapy

H. Sasaki, Hisaichi Tanaka, M. Okumura, 2005 .

EGFR polymorphism of the kinase domain in Japanese lung cancer.

H. Sasaki, M. Takada, M. Yano, 2008, The Journal of surgical research.

A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer

H. Sasaki, M. Takada, M. Yano, 2008, Journal of Cancer Research and Clinical Oncology.

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

H. Sasaki, M. Takada, M. Yano, 2008, Journal of Cancer Research and Clinical Oncology.

L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.

H. Sasaki, M. Takada, M. Yano, 2006, Lung cancer.

Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy.

H. Sasaki, M. Yano, Y. Fujii, 2006, Oncology reports.

Decreased kallikrein 11 messenger RNA expression in lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2006, Clinical lung cancer.

Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas

D. Auclair, H. Sasaki, Y. Yamakawa, 2001, Cancer.

Clinicopathological analysis of small-sized anterior mediastinal tumors

H. Sasaki, S. Moriyama, M. Yano, 2014, Surgery Today.

Middle lobe preservation and fixation: right upper and lower sleeve bilobectomy. How to do it

H. Sasaki, S. Moriyama, M. Yano, 2012, Surgery Today.

Factors associated with outcome of segmentectomy for non-small cell lung cancer: long-term follow-up study at a single institution in Japan.

H. Sasaki, Hisaichi Tanaka, M. Okumura, 2007, Lung cancer.

Human MOB1 expression in non-small-cell lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2007, Clinical lung cancer.

APOBEC3B gene overexpression in non-small-cell lung cancer

H. Sasaki, S. Moriyama, M. Yano, 2014, Biomedical reports.

RET expression and detection of KIF5B/RET gene rearrangements in Japanese lung cancer

H. Sasaki, S. Moriyama, M. Yano, 2012, Cancer medicine.

Overexpression of Hrad17 gene in non-small cell lung cancers correlated with lymph node metastasis.

D. Auclair, H. Sasaki, S. Moriyama, 2001, Lung cancer.

Elevated Serum Epidermal Growth Factor Receptor Level in Stage IV Thymoma

H. Sasaki, M. Yano, Y. Fujii, 2004, Surgery Today.

The detectability of the pretreatment EGFR T790M mutations in lung adenocarcinoma using CAST-PCR and digital PCR.

H. Sasaki, S. Moriyama, A. Suzuki, 2017, Journal of thoracic disease.

Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer.

H. Sasaki, M. Yano, Y. Fujii, 2008, Oncology reports.

Analysis of change in anti‐acetylcholine receptor antibody and effect on myasthenia gravis symptoms by adjusting tacrolimus dosage according to the blood concentration

H. Sasaki, S. Moriyama, M. Yano, 2015 .

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor

C. Berking, H. Sasaki, N. Harbeck, 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.

H. Sasaki, S. Moriyama, M. Yano, 2012, Oncology reports.

EGFR mutation status and prognosis for gefitinib treatment in Japanese lung cancer.

H. Sasaki, M. Yano, Y. Yamakawa, 2006, Lung cancer.

Keap1 mutations in lung cancer patients

H. Sasaki, S. Moriyama, M. Yano, 2013, Oncology letters.

Erratum: Corrigendum: High-throughput oncogene mutation profiling in human cancer

S. Gabriel, S. Nelson, M. Meyerson, 2007 .

Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma.

H. Sasaki, S. Kondo, Y. Yamakawa, 2001, Cancer Letters.

Increased FGFR1 copy number in lung squamous cell carcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2011, Molecular medicine reports.

Elevated plasma thymosin-alpha1 levels in lung cancer patients.

H. Sasaki, Y. Yamakawa, M. Kiriyama, 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

ErbB 3mRN AExpressio nCorrelate dwit hSpecifi cClinicopathologic Feature so fJapanes eLun gCancers

H. Sasaki, M. Yano, Y. Fujii, 2008 .

Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma

H. Sasaki, M. Yano, Y. Fujii, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

S. Gabriel, M. Meyerson, W. Sellers, 2004, Science.

Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas.

H. Sasaki, S. Moriyama, M. Yano, 2011, Molecular medicine reports.

Characterizing the cancer genome in lung adenocarcinoma

Derek Y. Chiang, S. Gabriel, E. Lander, 2007, Nature.

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma

H. Sasaki, M. Yano, Y. Fujii, 2008, Journal of Cancer Research and Clinical Oncology.

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

H. Sasaki, N. Kondo, T. Toyama, 2008, BMC Cancer.